BYDUREON: payments to doctors
Payments that named BYDUREON as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $698K
- Providers
- 6,927
- Transactions
- 14,906
- Average per transaction
- $47
The per-transaction average — $47 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,927 providers the average total is $101, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $697,850 | 100.0% |
| Acerta Pharma LLC | $180 | 0.0% |